La bourse ferme dans 16 min

The Europe smart inhalers market is expected to reach US$ 2,129.61 Mn in 2027 from US$ 302.40 Mn in 2018

ReportLinker FR

The market is estimated to grow with a CAGR of 24. 9% from 2019-2027. The growth of the smart inhalers market is primarily attributed to the growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition as well as the presence of supportive associations in the region.

New York, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Smart Inhalers Market to 2027 - Regional Analysis and Forecasts by Product; Disorder; End User, and Country" - https://www.reportlinker.com/p05828381/?utm_source=GNW
However, risks associated with cyber threats with smart inhalers are likely to pose a negative impact on the market growth.

On the other hand, development of growth in the Europe healthcare market is likely to have a positive impact on the growth of the Europe smart inhalers market in the coming years.
With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Europe. Some of the factors leading to growth in the number of asthma and COPD cases across the Europe are rise in air pollution levels and increasing smoking habits.
The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies.As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants.

Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into lungs and the cardiovascular system.This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others.

Studies reveal, above 90% of air pollution-related deaths worldwide occur in low- and middle-income countries of the Eastern Mediterranean, European regions.According to world health organization (WHO), about 21,000 premature deaths per year in European region because of air pollution like Ozone pollution courses breathe difficulties, triggers asthma symptoms, and causes lung and heart diseases.

Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a largest contributor of the climate change. As per data published by World Health Organization (WHO) Some 40 million people in the 115 largest cities in the European Union (EU) are exposed to air exceeding WHO air quality guideline values for at least one pollutant. Children that live close by the traffic of heavy duty vehicle have a high risk of respiratory then those living near less congested streets. Hence, the rising levels of air pollution coupled is anticipated to drive the demand for smart inhalers market during the forecast period.
In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product.The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma.

The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
Home-care setting segment a largest market share of the smart inhalers market, by end user in 2018.This segment is also expected to dominate the market in 2027.

As smart inhaler devices are connected digitally, enabling the patients to get advice from their physicians, even when situated far away. Home-care setting segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.
Some of the major primary and secondary sources for smart inhalers included in the report are, GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG, Findair Sp. z o. o., Cohero Health, Crux Product Design Ltd, Teva Pharmaceuticals, 3M, Amiko Digital Health Limited, and others.
Read the full report: https://www.reportlinker.com/p05828381/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001